Information processing in anxiety: A pilot study of the effect of manipulating 5-HT function

Journal of Psychopharmacology

Volumn 12, Issue 2, 1998, Pages 155-160

  Andrews, T M ^a   Anderson, I M ^b  

^a The Slade   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 HT; Anxiety disorders; Critical flicker fusion; D fenfluramine; Information processing; Methysergide; Stroop

Indexed keywords

FENFLURAMINE; METHYSERGIDE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEROTONIN BRAIN LEVEL; VISUAL INFORMATION;

EID: 0031862631     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200207     Document Type: Article

References (52)

1. Anderson I M, Deakin J F W, Miller H (1996) Effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology 128: 74-82
2. Apostolopoulos M, Judd F K, Burrows C D, Norman T R (1993) Prolactin response to dl-fenfluramine in panic disorder. Psychoneuroendocrinology 18: 337-342
3. Beck A T, Ward C H, Mendelson M, Mock J E, Erbaugh J E (1961) An inventory for measuring depression. Archs Gen Psychiat 4: 561-567
4. Bond A J, Feizollah S, Lader M H (1995) The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function. Psychopharmacology 9: 1-8
5. Boyer W (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmac 10: 45-49
6. Bredberg U, Eyjolfsdottir G S, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V (1986) Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharm 30: 75-77
7. Caccia S, Ballabio M, De Ponte P (1979) Pharmacokinetics of fenfluramine enantiomers in man. Eur J Drug Metab Pharmacokin 4: 129-132
8. Campbell D B (1991) Dexfenfluramine: an overview of its mechanisms of action. Rev Contemp Pharmac 2: 93-113
9. Carroll J B, Davies P, Richman B (1971) Word frequency book. American Heritage, New York
10. Caycedo N, Connell J, Hellewell J S E, Deakin J F W (1994) Effect of fenfluramine on executive and other cognitive functions. J Psychopharmac (abstract book): A43
11. 2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126: 24-30
12. Deakin J F W, Graeff G F (1991) 5-HT and mechanisms of defence. J Psychopharmac 5: 305-315
13. Feeney S, Goodall E, Silverstone T (1996) The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood. Int Clin Psychopharmac 11: 89-99
14. Frewer L J, Lader M (1993) The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects. Int Clin Psychopharmac 8: 13-20
15. Garrattini S, Caccia S, Mennini T, Samanin R, Consolo S, Ladinsky H (1979) Biochemical pharmacology of the anorectic drug fenfluramine: a review. Curr Med Res Opin 6: 15-27
16. Golombok S, Stavrou A, Bonn J, Mogg K, Critchlow S, Rust J (1991) The effects of diazepam on anxiety-related cognition. Cogn Ther Res 15: 459-467
17. Goodall E M, Cowen P J, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology 112: 461-466
18. Hale A S, Pinninti N R (1995) Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives. J Clin Psychopharmac 9: 258-266
19. Hayward P, Ahmad T, Wardle J (1994) Into the dangerous world: an in vivo study of information processing in agoraphobics. Br J Clin Psychol 33: 307-315
20. Hindmarch I (1994) Relevant psychometric tests for antidepressant and anxiolytics. Int Clin Psychopharmac 9: 27-33
21. Hindmarch I (1995) The behavioural toxicity of the selective serotonin reuptake inhibitors. Int Clin Psychopharmac 9: 13-17
22. Hindmarch I, Alford C, Barwell F, Kerr J S (1992) Measuring the side-effects of psychotropics: the behavioural toxicity of antidepressants. J Psychopharmac 6: 198-203
23. Judd F K, Apostolopoulos M, Burrows G D, Norman T R (1994) Serotonergic function in panic disorder:endocrine responses to D-fenfluramine. Prog Neuro-Psychopharmac Biol Psychiat 18: 329-337
24. Kahn R S, Moore C (1993) Serotonin in the pathogenesis of anxiety. In Hoehn-Saric R, McLeod D R (eds), Biology of anxiety disorders. American Psychiatric Press, Washington DC, pp. 61-102
25. Kerr J S, Hindmarch I (1991) Effects of ketanserin on psychomotor performance, mood and sleep. Med Sci Res 19: 493-494
26. Kuyk T K, Wesson M D (1991) Aging-related foveal flicker sensitivity losses in normal observers. Optom Vis Sci 68: 786-789
27. Lachenmayr B J, Kojetinsky S, Ostermaier N, Angstwurm K, Vivell P M O, Schaumberger M (1994) The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Opth Vis Sci 35: 2741-2748
28. MacLeod C, Hagan R (1992) Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event. Behav Res Ther 30: 151-161
29. Mathews (1993) Biases in processing emotional information. The Psychologist 6: 493-499
30. Mathews A, Klug F (1993) Emotionally and interference with colornaming in anxiety. Behav Res Ther 31: 57-62
31. Mathews A, MacLeod C (1985) Selective processing of threat cues in anxiety states. Behav Res Ther 23: 563-569
32. McEntee W J, Crook T H (1991) Serotonin, memory, and the aging brain. Psychopharmacology 103: 143-149
33. McNair D M, Lorr M, Droppelman L F (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA
34. McNally R J, Riemann B C, Kim E (1990) Selective processing of threat cues in panic disorder. Behav Res Ther 28: 407-412
35. McNally R Riemann B C, Louro C E, Lukach B M, Kim E (1992) Cognitive processing of emotional information in panic disorder. Behav Res Ther 30: 143-149
36. Mogg K, Bradley B P, Williams R, Mathews A (1993a) Subliminal processing of emotional information in anxiety and depression. J Abnorm Psychol 102: 304-311
37. Mogg K, Kentish J, Bradley B P (1993b) Effects of anxiety and awareness on colour-identification latencies for emotional words. Behav Res Ther 31: 559-567
38. Mogg K, Bradley B P, Millar N, White J (1995) A follow-up study of cognitive bias in generalized anxiety disorder. Behav Res Ther 33: 927-935
39. Park S B, Coull J T, McShane R H, Young A H, Sahakian B J, Robbins T W, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33: 575-588
40. Parrott A C (1982) Critical flicker fusion threshold and their relationship to other measures of alertness. Pharmacopsychiatria 15: 49-56
41. Peroutka S J (1987) Serotonin receptors. In Meltzer H Y (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 303-311
42. Pinder R M, Rogden R M, Sawyer P R, Speight T M, Avery G S (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10: 241-328
43. Rammsayer T, Netter P (1988) Effects of changes in brain 5-HT activity on indicators of cortical arousal. Int Clin Psychopharmac 3: 231-237
44. Ramos R T, Gentil V, Gorenstein C (1993) Clomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'. J Psychopharmac 7: 265-269
45. Raven J C (1965) Guide to using the Mill Hill vocabulary scale with the progressive matrices scale. H.K. Lewis, London
46. Spielberger C D, Gorsuch R L, Lushese R E (1970): Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, CA
47. Spitzer R L, Williams J B, Gibbon M, First M B (1990) Structured clinical interview for DSM-III-R - patient edition (SCID-P, Version 1.0). American Psychiatric Press, Washington DC
48. Steckler T, Sahgal A (1995) The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 67: 165-199
49. Targum S D, Marshall L E (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiat Res 28: 295-306
50. Van Amerigen M, Mancini C, Streiner D L (1993) Fluoxetine efficacy in social phobia. J Clin Psychiat 54: 27-32
51. Wells A, Matthews G (1994): Attention and emotion: a clinical perspective. Lawrence Erlbaum Hillsdale, NJ
52. Weinstein A M, Nutt D J (1995) A cognitive dysfunction in anxiety and its amelioration by effective treatment with SSRIs. J Psychopharmac 9: 83-89